BioSpace News Archive

A first-of-its-kind tool may be able to help doctors better diagnose inflammatory breast cancer (IBC).

ATCC, the world’s premier biological materials management and standards organization, announced that it has been awarded three grants valued at over $5.5 million by the Defense Threat Reduction Agency (DTRA).

Takara Bio USA, Inc. (TBUSA) today announced that the European Patent Office has reviewed and confirmed the validity of TBUSA’s granted European patent EP 3105325, entitled “Methods of depleting a target molecule from an initial collection of nucleic acids, and compositions and kits for practicing the same.”

Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the launch of Spanish-language availability for reSET® and reSET-O®, the only FDA-authorized PDTs for the treatment of substance use disorder (SUD) and opioid use disorder (OUD), respectively.

Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that the company is scheduled to present at Aegis Virtual Conference.

Palisade Bio, Inc. (NASDAQ: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, announced today that Robert McRae has joined the senior management team as Senior Vice President, Operations and Strategic Development.

NRx Pharmaceuticals (Nasdaq: NRXP), a clinical-stage, biopharmaceutical company, today announced results of a review conducted by the Therapeutics and Prevention Data Safety and Monitoring Board (DSMB) of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) on February 14, 2022.

Axon Therapies, a private company focused on addressing a root cause of heart failure, today announced the appointment of Brian Farley to the company’s Board of Directors.

Natera, Inc., a global leader in cell-free DNA testing, announced that Steve Chapman, chief executive officer, and Mike Brophy, chief financial officer, will provide an update on recent business activities in the following upcoming investor conferences.

Champions Oncology, Inc. announced today a co-development partnership with GigaMune.